A comprehensive view of AptarGroup Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
AptarGroup's Otrivin Nasal Mist nominated for CPhI Pharma Award; company opens InVision Lab near Paris to foster innovation in drug delivery and packaging solutions
Published:
September 18, 2024
by Industry Intelligence Inc.
|
AptarGroup Inc. unveils sustainable 2" Disc Top Lite closure; company advances liquid nutritional supplements technology for nutraceutical industry
Published:
September 17, 2024
by Industry Intelligence Inc.
|
AptarGroup to showcase drug delivery innovations, sustainable packaging at CPHI Milan; company introduces Color Code Screw refillable fragrance pump with customizable plastic finish
Published:
September 12, 2024
by Industry Intelligence Inc.
|
Aptar Pharma partners with PULMOTREE for Kolibri Non-Propellant Liquid Inhaler platform; Aptar to lead development, promotion, customer support for alternative to propellant-based systems
Published:
September 09, 2024
by Associated Press
|
Wells Fargo: Aptar highlights strong pipelines within Pharma segment, fueling confidence to achieve 7%-11% long-term organic growth target; recent FDA approval of nasal epinephrine Neffy expected to contribute US$18M-US$20M EBITDA by 2026
Published:
September 06, 2024
by Wells Fargo & Co.
|
Ask us about our Health Care Sector market view